Chi Meng Fong
Stock Analyst at Bank of America Securities
(0.52)
# 3,937
Out of 4,339 analysts
38
Total ratings
28.6%
Success rate
-18.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chi Meng Fong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintained: Hold | $30 → $32 | $29.67 | +6.19% | 24 | May 25, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $21 | $14.17 | +48.20% | 3 | May 19, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $25 | $18.81 | +32.91% | 1 | May 7, 2026 | |
| CCCC C4 Therapeutics | Rated: Hold | n/a | $3.49 | n/a | 5 | Oct 31, 2023 | |
| FHTX Foghorn Therapeutics | Rated: Hold | n/a | $4.37 | n/a | 5 | Oct 6, 2023 |
Roivant Sciences
May 25, 2026
Maintained: Hold
Price Target: $30 → $32
Current: $29.67
Upside: +6.19%
Relay Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $21
Current: $14.17
Upside: +48.20%
Amphastar Pharmaceuticals
May 7, 2026
Reiterated: Hold
Price Target: $25
Current: $18.81
Upside: +32.91%
C4 Therapeutics
Oct 31, 2023
Rated: Hold
Price Target: n/a
Current: $3.49
Upside: n/a
Foghorn Therapeutics
Oct 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.37
Upside: n/a